Elevated Triglyceride-Glucose (TyG) Index Predicts Poor Clinical Outcomes in Critically Ill AECOPD Patients: A Retrospective Study
Xin Wang,Xuerong Cui,Huaping Fan,Tianyang Hu
DOI: https://doi.org/10.2147/copd.s477268
2024-10-01
International Journal of COPD
Abstract:Xin Wang, 1, &ast Xuerong Cui, 2, &ast Huaping Fan, 3 Tianyang Hu 4 1 Department of Respiratory and Critical Care Medicine, Deyang People's Hospital, Deyang, Sichuan, 618099, People's Republic of China; 2 Department of Respiratory Medicine, People's Hospital of Shizhu Tujia Autonomous County, Chongqing, 409199, People's Republic of China; 3 Department of Cardiology, 63650 Military Hospital, Urumqi, Xinjiang, 841700, People's Republic of China; 4 Precision Medicine Center, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, People's Republic of China &astThese authors contributed equally to this work Correspondence: Huaping Fan, Email ; Tianyang Hu, Email Purpose: The triglyceride-glucose (TyG) index is a surrogate biomarker of insulin resistance which has been widely used in intensive care unit (ICU) to predict prognosis. However, its role in critically ill acute exacerbation of COPD (AECOPD) patients remains largely unknown. Material and methods: A total of 645 AECOPD patients were induced in this retrospective cohort study, which extracted data from the eICU Collaborative Research Database (eICU-CRD). The TyG index was calculated as Ln (fasting triglycerides (mg/dL) × fasting plasma glucose (mg/dL)/2). The primary endpoint includes in-hospital mortality and ICU mortality. The secondary endpoint was sepsis, acute kidney injury (AKI), and acute respiratory failure (ARF). Results: Multivariable Cox regression analysis revealed that the TyG index was independently associated with an increased risk of in-hospital mortality (hazard ratio, HR: 1.45, 95% CI: 1.04– 2.01, P = 0.028) and ICU mortality (HR: 2.13, 95% CI: 1.28– 3.54, P = 0.004). Moreover, the TyG index was independently associated with an increased risk of sepsis (odds ratio, OR: 1.54, 95% CI: 1.24– 1.93, P < 0.001), AKI (OR: 1.57, 95% CI: 1.26– 2.02, P < 0.001) and ARF (OR: 1.50, 95% CI: 1.20– 1.87, P < 0.001). Kaplan–Meier survival analysis revealed that higher TyG indexes were also related to increased in-hospital mortality and ICU mortality. In addition, the restricted cubic splines regression model demonstrated that the in-hospital mortality and ICU mortality increased linearly with increasing TyG index (P for non-linearity = 0.897, P for non-linearity = 0.897, respectively). Conclusion: Elevated TyG index was independently associated with an increased risk of poor clinical outcomes in critically ill AECOPD patients. A prospective study to define TyG as a biomarker for prognosis prediction in critically ill AECOPD patients is warranted. Keywords: triglyceride-glucose index, AECOPD, mortality, eICU-CRD database Chronic obstructive pulmonary disease (COPD) is characterized by expiratory airflow limitation that is not fully reversible, deregulated chronic inflammation, and emphysematous destruction of the lungs, which has a high mortality worldwide and is the fifth leading cause, COPD is caused by exposure to inhaled noxious particles, notably tobacco smoke and pollutants. Its incidence rate is about 12%, and 3 million deaths annually due to COPD. 1,2 The important causes of exacerbations include airway bacteria, viruses, and pollution; frequent acute exacerbation of COPD (AECOPD) is strongly associated with higher mortality, accelerates the deterioration in lung function, and lowers the quality of life of the patient. AECOPD is a major health issue that leads to hospitalization of patients, as it affects disease outcomes and household expenses. It was reported that the 1-year mortality rate of AECOPD patients is about 25%. 3,4 Under certain conditions, AECOPD can lead to acute respiratory failure, leading to rapid deterioration of the condition, requiring tracheal intubation and invasive mechanical ventilation, which consume large ICU resources. Due to these reasons, severe AECOPD causing acute or acute chronic respiratory failure typically requires ICU admission, where the clinical course may be complicated by concurrent multiple organ dysfunction, which has a high mortality. 5,6 The mortality in AECOPD patients admitted to the ICU was extremely high, particularly those who require invasive mechanical ventilation.One study found mortality rates AECOPD patients admitted to the ICU at 6-months, 1-year, and 5-years from hospitalization of 39.0%, 42.7% and 75.9%, respectively. 7 The mortality rate for critically ill AECOPD patients remains high despite numerous attempts. Therefore, it is critical to determine the possible risk factors for critically ill AECOPD patients in order to potentially improve the prognosis of thos -Abstract Truncated-
respiratory system